Stay
up-to-date
about
RECOVER
Our understanding of Long COVID is constantly evolving with new research findings. Stay informed by reading the latest news and participating in upcoming events.
Results from a recent RECOVER study suggest that adults who have COVID-19 may be more likely to develop a related condition called myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
The journal PLOS ONE has published the full RECOVER study design for babies, children, adolescents, and young adults taking part in RECOVER studies.
During the May 14th RECOVER Research Review (R3) Seminar, researchers presented findings from the RECOVER pregnancy observational cohort and EHR cohort about the association of SARS-CoV-2 infection during pregnancy and development of Long COVID.
RECOVER-ENERGIZE and RECOVER-SLEEP will test multiple treatments for sleep disturbances, difficulties exercising, and worsening Long COVID symptoms after physical, mental, or emotional activity.
De-identified data from thousands of adults with Long COVID are now available to researchers.
During the April 23rd, RECOVER Research Review (R3) Seminar, the speakers discussed our current knowledge of Long COVID in children, including epidemiology and risk factors, symptoms, underlying mechanisms that cause symptoms, and functional outcomes.
During the March 19th RECOVER Research Review (R3) Seminar, research presented findings about vaccine effectiveness against Long COVID in children and the association between SARS-CoV-2 infection and symptoms and conditions in children and adults.
During the February 13th RECOVER Research Review (R3) Seminar, several pathobiology study awardees presented about the mechanisms of neurological (brain and nervous system) symptoms of Long COVID.
Media InquiriesAre you a member of the media or press? Please direct inquiries to the RECOVER@nih.gov inbox. Please place "MEDIA INQUIRY" in your subject line.